Mode
Text Size
Log in / Sign up

Mini review examines sudden cardiac death risks in marathon runners across different age groups

Mini review examines sudden cardiac death risks in marathon runners across different age groups
Photo by Capstone Events / Unsplash
Key Takeaway
Note that SCD risk is higher in older men and full-marathon participants, though absolute incidence remains low.

This mini review examines the etiological spectrum and risk factors for sudden cardiac death (SCD) among marathon runners. The scope covers coronary artery disease, cardiomyopathies, and congenital coronary anomalies within the context of marathon races. The authors synthesize findings indicating that SCD risk is higher in men, older runners, and full-marathon participants. Most cardiac arrest events occur in the final phase of the race or shortly after finishing.

Regarding the etiological spectrum, coronary artery disease remains the predominant cause in middle-aged and older runners. In contrast, inherited cardiomyopathies, congenital coronary anomalies, and myocarditis are more relevant in younger athletes. The review does not report specific absolute numbers, p-values, or confidence intervals for these associations. The authors explicitly state that the absolute incidence of marathon-associated SCD is low.

The authors acknowledge important controversies persist regarding optimal screening intensity, interpretation of subclinical findings, and the dose-response relationship between extreme endurance exercise and cardiovascular risk. Future efforts should prioritize precision risk stratification, longitudinal evaluation of subclinical cardiovascular abnormalities, integration of wearable monitoring technologies, and standardized race-day emergency preparedness to improve the safety of long-distance running.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Marathon running is widely promoted for its cardiovascular and overall health benefits, yet rare cases of sudden cardiac death (SCD) during long-distance races continue to raise substantial clinical and public health concerns. Although the absolute incidence of marathon-associated SCD is low, its catastrophic nature necessitates a clearer understanding of risk perception, epidemiological patterns, pathophysiological mechanisms, and preventive strategies. This mini review synthesizes current evidence on the incidence, demographic characteristics, etiological spectrum, and temporal features of cardiac arrest and SCD during marathon running. Available data indicate that risk is higher in men, older runners, and full-marathon participants, with most events occurring in the final phase of the race or shortly after finishing. Coronary artery disease remains the predominant cause in middle-aged and older runners, whereas inherited cardiomyopathies, congenital coronary anomalies, and myocarditis are more relevant in younger athletes. We further discuss the mechanistic basis of exercise-triggered fatal events, including acute ischemia, malignant ventricular arrhythmias, myocardial fibrosis, and inflammatory myocardial injury. Current preventive approaches, including pre-participation cardiovascular screening, electrocardiography, advanced imaging, genetic evaluation in selected individuals, and rapid on-site resuscitation systems, have improved event recognition and survival outcomes, but important controversies persist regarding optimal screening intensity, interpretation of subclinical findings, and the dose-response relationship between extreme endurance exercise and cardiovascular risk. Future efforts should prioritize precision risk stratification, longitudinal evaluation of subclinical cardiovascular abnormalities, integration of wearable monitoring technologies, and standardized race-day emergency preparedness to improve the safety of long-distance running.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.